Fatty Liver as a Potential Surrogate for Waist Circumference in the Diagnosis of Metabolic Syndrome: A Population-Based Study among Chinese Adults
Table 2
Prevalence of MetS components and the odds ratios (ORs) for developing an abnormality among the study population, grouped by WC and NAFLD.
Normal WC
Abnormal WC
Without NAFLD (1)
With NAFLD (2)
Without NAFLD (3)
With NAFLD (4)
Per (%)
OR
Per (%)
OR (95% CI)
Per (%)
OR (95% CI)
Per (%)
OR (95% CI)
BG disorder
Crude
19.20
1.0
52.00
1.51 (1.30, 1.74)
34.40
1.67 (1.49, 1.86)
59.50
2.61 (2.33, 2.92)
Adjusted
1.0
1.76 (1.50, 2.07)
1.22 (1.08, 1.37)
2.29 (2.03, 2.58)
TG disorder
Crude
15.40
1.0
20.20
4.57 (3.95, 5.28)
28.70
2.21 (1.97, 2.49)
34.20
6.20 (5.51, 6.98)
Adjusted
1.0
3.96 (2.26, 6.12)
3.40 (1.98, 5.40)
4.62 (2.57, 6.94)
HDL disorder
Crude
46.40
1.0
59.90
1.39 (1.16, 1.65)
71.50
2.21 (1.95, 2.50)
78.70
2.84 (2.51, 3.22)
Adjusted
1.0
2.06 (1.70, 2.50)
2.04 (1.77, 2.35)
2.99 (2.61, 3.44)
BP disorder
Crude
27.70
1.0
36.60
1.73 (1.50, 1.99)
38.90
2.89 (2.58, 3.25)
49.90
4.26 (3.75, 4.84)
Adjusted
1.0
1.62 (1.38, 1.91)
2.05 (1.8, 2.34)
3.63 (3.15, 4.18)
≥2 MetS factors (exclude WC)
Crude
31.30
1.0
58.30
3.07 (2.66, 3.54)
55.90
2.78 (2.49, 3.10)
75.40
6.73 (5.94, 7.62)
Adjusted
1.0
3.3 (2.82, 3.86)
2.13 (1.89, 2.40)
6.07 (5.32, 6.93)
≥3 MetS factors (exclude WC)
Crude
8.40
1.0
22.50
3.19 (2.66, 3.83)
23.20
3.32 (2.87, 3.84)
41.30
7.71 (6.72, 8.85)
Adjusted
1.0
3.35 (2.76, 4.06)
2.67 (2.29, 3.12)
6.93 (6.00, 8.01)
4 MetS factors (exclude WC)
Crude
1.10
1.0
4.00
3.91 (2.57, 5.94)
5.40
5.32 (3.81, 7.42)
10.20
10.58 (7.77, 14.39)
Adjusted
1.0
4.52 (2.91, 7.02)
3.57 (2.51, 5.06)
8.16 (5.93, 11.24)
Data were shown as percentages (%). Abdominal WC: WC ≥ 90 cm for males and WC ≥ 80 cm for females; normal WC: <90 cm for males and <80 cm for females. The estimates of the associations were adjusted for age, sex, living area, occupation, and smoking status.
